Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Switching Patients with Non-Dialysis Chronic Kidney Disease from Oral Iron to Intravenous Ferric Carboxymaltose: Effects on Erythropoiesis-Stimulating Agent Requirements, Costs, Hemoglobin and Iron Status

PaperCitations, authors & open-access status

Switching Patients with Non-Dialysis Chronic Kidney Disease from Oral Iron to Intravenous Ferric Carboxymaltose: Effects on Erythropoiesis-Stimulating Agent Requirements, Costs, Hemoglobin and Iron Status is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 18 citations, 2015 year and gold oa status.

18
Citations
2015
Year
gold
OA Status

Related on ScholarIQ

Federico Di Gennaro
Author
PLoS ONE
Journal
Erythropoietin and Anemia Treatment
Topic
Erythropoietin and Anemia Treatment
Topic
Iron Metabolism and Disorders
Topic
Dialysis and Renal Disease Management
Topic
470M+ articles · free account